BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Gritstone Oncology Announces First Patient Dosed with SLATE, its “Off-The-Shelf” Neoantigen Immunotherapy

  First patient dosed is a metastatic non-small cell lung cancer patient with a KRAS G12C mutation

  August 15, 2019

   · 

  6 min read
• Deals

  Salveo Diagnostics Merges Two Local Companies into its Growing Portfolio

  Addition of ImmunArray autoimmune testing assets, Nudge patient-engagement capabilities enhances diagnostic and patient support offerings

  August 15, 2019

   · 

  3 min read
• 

  Drug Development

  After Suspending Generics Spin-Off, Mallinckrodt Eyes Potential FDA Approval of Liver Disease Drug

  Mallinckrodt’s experimental drug terlipressin hit the mark in a late-stage liver disease trial. Mallinckrodt said terlipressin met its primary endpoint in reversing three components of hepatorenal syndrome type 1.

  August 15, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  After AbbVie Acquisition, Allergan’s Saunders Can Walk Away with $39 Million

  According to a regulatory filing, Saunders will walk away with $14.9 million in cash and $23.6 million in equity, mostly stock based on performance.

  August 15, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Evotec Se Reports First Half-Year 2019 Results And Corporate Updates

  Evotec SE reported financial results and corporate updates for the first half of 2019.

  August 15, 2019

   · 

  15 min read
• Job Trends

  Saranas Recognized as One of Houston’s Most Innovative Companies

  Saranas Inc. announced that it has been named one of Houston’s most innovative companies.

  August 15, 2019

   · 

  1 min read
• 

  Biotech Bay

  Research Roundup: Radical Insights into Cellular Dark Matter and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  August 15, 2019

   · 

  5 min read

   · 

  Mark Terry
• Deals

  InflaRx Reports Second Quarter 2019 Financial & Operating Results

  InflaRx reported financial and operating results for the second quarter ended June 30, 2019.

  August 15, 2019

   · 

  7 min read
• Biotech Bay

  European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis

  In early July, Gilead announced plans to submit a New Drug Application (NDA) for filgotinib for the treatment of RA in the United States before the end of the year.

  August 15, 2019

   · 

  7 min read
• Business

  Accuray Reports Fourth Quarter and Fiscal 2019 Financial Results

  Revenue increased 3 percent to $117.4 million, the highest ever quarterly revenue reported; Gross orders increased to $97.2 million

  August 15, 2019

   · 

  13 min read